The Role of Artificial Intelligence in the Treatment of Abdominal Aortic Aneurysms

Sponsor
Meshalkin Research Institute of Pathology of Circulation (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05643664
Collaborator
(none)
100
4
2
24
25
1

Study Details

Study Description

Brief Summary

"Pilot randomized prospective clinical study of the effectiveness of the use of artificial intelligence in determining "safe" clamping zones in the surgical treatment of abdominal aortic aneurysms."

Condition or Disease Intervention/Treatment Phase
  • Procedure: prosthetics of the abdominal aorta
  • Procedure: prosthetics of the abdominal aorta after determining the safe zones of clamping
N/A

Detailed Description

Abdominal aortic aneurysm is a life-threatening disease, a formidable complication of which is an aneurysm rupture (Editor's Choice - European Society for Vascular Surgery). The main method of treating aneurysms is surgical reconstruction, including open or endovascular intervention ((ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms). Anatomical features of aneurysms and the presence of intraluminal thrombomass are among the criteria in deciding on the tactics of surgical treatment. These factors carry additional technical difficulties and lead to the development of intraoperative complications, including ischemic ones. Ischemia of the lower extremities is the most common complication and can be caused by thrombosis, embolism or dissection of the aortic wall (occurs in 7% of patients) (Complications Associated with Aortic Aneurysm Repair).

Thus, in order to reduce the frequency of embolic complications, it is important for the surgeon to determine a "safe" zone for applying a clamp to the aorta and main vessels. Thus, artificial intelligence (AI) can be used to interpret and analyze images of aneurysms that allow automatic quantitative measurements and determination of the exact characteristics of morphology and hydrodynamics, as well as the presence of intraluminal blood clots and calcifications. Analysis based on artificial intelligence can lead to the development of computational programs for predicting the development of aneurysms and the risk of their rupture, as well as postoperative outcomes. Artificial intelligence can also be used to determine the "safe" areas of aortic clamping. (Artificial intelligence in abdominal aortic aneurysm).

Adam and co-authors trained a neural network to detect and estimate the maximum outer diameter of aneurysms using a database of 489 CT angiographs of abdominal aortic aneurysms. AI has achieved a level of performance and accuracy suitable for clinical practice, and with the use of more CT images, further improvement in accuracy is expected (Pre-surgical and Post-surgical Aortic Aneurysm Maximum Diameter Measurement: Full Automation by Artificial Intelligence). In a study by Fujiwara et al. 145 non-contrast CT scans with suspected aneurysm were retrospectively collected. Initially, AI was trained by manually segmenting CT images. Image processing was used to determine the abdominal aortic aneurysm area and to automatically measure the size. This method has shown that AI is a useful tool for fully automatic detection and measurement of aneurysm diameter. (Fully automatic detection and measurement of abdominal aortic aneurysm using artificial intelligence). Florent Lalys and his coauthor. an automatic fast and universal algorithm for determining an intraluminal thrombus was developed. The method was tested on pre- and postoperative CT scans of the abdominal aorta and iliac artery of 145 patients and consists in determining the central line and segmentation of the aortic lumen, an optimized stage of pretreatment and the use of a 3D model (Generic thrombus segmentation from pre- and post-operative CTA).

Taking into account the references already available in some studies of the use of artificial intelligence for the treatment of cardiovascular diseases, its use is seen as a promising method for making decisions in determining "safe" clamping zones in the surgical treatment of abdominal aortic aneurysms, which will reduce the frequency of postoperative complications.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
In both groups, aneurysmectomy with prosthetics of the abdominal aorta is performed using the standard technology. In the first group, the aortic and main artery clamping zone is determined by the surgeon intraoperatively. In the second group, before surgery, multispiral computed tomography data is evaluated using artificial intelligence and the definition of "safe" areas of aortic and main artery clamping is performed. Intraoperatively, clamping is performed in the settlement zones.In both groups, aneurysmectomy with prosthetics of the abdominal aorta is performed using the standard technology. In the first group, the aortic and main artery clamping zone is determined by the surgeon intraoperatively. In the second group, before surgery, multispiral computed tomography data is evaluated using artificial intelligence and the definition of "safe" areas of aortic and main artery clamping is performed. Intraoperatively, clamping is performed in the settlement zones.
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
"Pilot Randomized Prospective Clinical Study of the Effectiveness of the Use of Artificial Intelligence in Determining the "Safe" Clamping Zones in the Surgical Treatment of Abdominal Aortic Aneurysms
Anticipated Study Start Date :
Jan 1, 2023
Anticipated Primary Completion Date :
Dec 31, 2023
Anticipated Study Completion Date :
Dec 31, 2024

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Standart technology

the zone of aortic and main artery clamping is determined by the surgeon intraoperatively.

Procedure: prosthetics of the abdominal aorta
aneurysmectomy is performed with prosthetics of the abdominal aorta using the standard technology.

Experimental: Artificial intellect

The multispiral computed tomography data is evaluated using artificial intelligence and the definition of "safe" zones of aortic and main artery clamping is performed. Intraoperatively, clamping is performed in the settlement zones.

Procedure: prosthetics of the abdominal aorta after determining the safe zones of clamping
aneurysmectomy is performed with prosthetics of the abdominal aorta using the standard technology. Before surgery, multispiral computed tomography data is evaluated using artificial intelligence and safe zones of aortic and arterial clampings are determined. Intraoperatively, clamping is performed in the settlement zones.

Outcome Measures

Primary Outcome Measures

  1. frequency of intraoperative and early postoperative embolism [12 months]

    Number of intraoperative embolism according to intraoperative ultrasound monitoring. The number of developed occlusions of peripheral arteries according to ultrasound scanning

Secondary Outcome Measures

  1. Primary patency of the operated segment. [12 months]

    The number of restenosis (50% or more) or reocclusion according to ultrasound duplex scanning of the operated segment at control points

  2. secondary patency of the operated segment [12 months]

    The number of restenosis (50% or more) or reocclusion according to ultrasound duplex scanning of the operated segment after repeated intervention at control points

  3. MALE [12 months]

    The number of major adverse events that occurred in the extremities the observation period

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with aneurysmal dilation of the abdominal aorta, who are shown surgery.

  • Patients who have agreed to participate in this study

Exclusion Criteria:
  • Chronic heart failure of functional class III -IV according to NYHA classification;

  • Chronic decompensated "pulmonary" heart;

  • Severe hepatic or renal insufficiency (bilirubin >35 mmol/l, glomerular filtration rate <60 ml/min);

  • Polyvalent drug allergy;

  • Malignant oncological diseases in the terminal stage with a predicted life span of up to 6 months;

  • Acute cerebrovascular accident;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alexander A Gostev Novosibirsk Novosibirskaya Obl Russian Federation 630005
2 Federal State Institution Academician E.N.Meshalkin Novosibirsk State Research Institute Of Circulation Pathology Rusmedtechnology Novosibirsk Russian Federation 630055
3 Novosibirsk Research Institute of Circulation Pathology Novosibirsk Russian Federation 630055
4 E. Meshalkin National Medical Research Center Novosibirsk Russian Federation

Sponsors and Collaborators

  • Meshalkin Research Institute of Pathology of Circulation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Meshalkin Research Institute of Pathology of Circulation
ClinicalTrials.gov Identifier:
NCT05643664
Other Study ID Numbers:
  • NRICP-16/11/22
First Posted:
Dec 9, 2022
Last Update Posted:
Dec 15, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Meshalkin Research Institute of Pathology of Circulation
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 15, 2022